Tobin W Juvenal, Chief Commercial Officer at Castle Biosciences, sold CSTL on Aug 25, 2026
Data as of Oct 16
▼ SELL$317K9,050 shares at $35.04Tobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc
- Traded
- Aug 25, 2026
- Disclosed
- Aug 27, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
CSTL since disclosure
−6.7%
after the sale
Similar stocks (XLV) since disclosure
+3.0%
XLV — its sector index fund
Change in closing price from Aug 27, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.